Other languages Molecular Partners AG Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 21:30:00 03/05/2024 BST			5-day change	1st Jan Change
3.98 ^USD	+5.71%		+2.58%	-4.78%

04-29	Molecular Partners AG Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action	CI
03-15	Transcript : Molecular Partners AG, 2023 Earnings Call, Mar 15, 2024

Morning Briefing - Markt Schweiz	04-30
Molecular Partners mit positivem Expertenbericht zum Leukämie-Kandidat MP0533	04-29
Molecular Partners AG Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533's Proposed Mechanism of Action	04-29
Principales informations avant-Bourse	04-18
Morning Briefing - Markt Schweiz	04-17
Morning Briefing - Markt Schweiz	04-16
Morning Briefing - Markt Schweiz	04-15
Morning Briefing - Markt Schweiz	04-08
Principales informations avant-Bourse	04-08
Molecular Partners : Einladung zur ordentlichen Generalversammlung 2024	03-20
Morning Briefing - Markt Schweiz	03-15
Principales informations avant-Bourse	03-15
Molecular Partners Swings to Loss in FY23; Revenue Down	03-15
Molecular Partners financé jusque loin en 2026	03-14
Molecular Partners sieht Finanzierung bis weit ins Jahr 2026 gesichert	03-14
Molecular Partners AG Reports Earnings Results for the Full Year Ended December 31, 2023	03-14
Morning Briefing - Markt Schweiz	03-14
Principales informations avant-Bourse	03-14
Morning Briefing - Markt Schweiz	03-13
Morning Briefing - Markt Schweiz	03-12

No results for this search